These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7538361)
1. [Contribution of chemotherapy in the treatment of cancer of the cavum (UCNT): apropos of 47 cases]. Poupart M; Damiano J; Bolot G; Biron P; Caldentey L; Ardiet JM; Pignat JC Bull Cancer; 1994 May; 81(5):366-70. PubMed ID: 7538361 [TBL] [Abstract][Full Text] [Related]
2. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480 [TBL] [Abstract][Full Text] [Related]
3. [Induction polychemotherapy before radiotherapy in carcinoma of the cavum. The experience of the Ibn Rochd-Casablanca Oncology Centre]. Samlali R; Acharki A; Sahraoui S; Benider A; Kahlain A Bull Cancer Radiother; 1996; 83(2):111-4. PubMed ID: 8688217 [TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy. Yeh SA; Tang Y; Lui CC; Huang EY Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357 [TBL] [Abstract][Full Text] [Related]
5. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
7. [Multimodality treatment of nasopharyngeal carcinoma]. Tanaka J; Inuyama Y; Fujii M; Takaoka T; Hosoda H; Kohno N Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1789-96. PubMed ID: 2439016 [TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120 [TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma. Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319 [TBL] [Abstract][Full Text] [Related]
11. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma. Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512 [TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399 [TBL] [Abstract][Full Text] [Related]
13. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases]. Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035 [TBL] [Abstract][Full Text] [Related]
14. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials. Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333 [TBL] [Abstract][Full Text] [Related]
15. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study. Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046 [TBL] [Abstract][Full Text] [Related]
16. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
17. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma. Cheng SH; Liu TW; Jian JJ; Tsai SY; Hao SP; Huang CH; Liu MC; Yu B; Huang AT Cancer J Sci Am; 1997; 3(2):100-6. PubMed ID: 9099460 [TBL] [Abstract][Full Text] [Related]
18. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526 [TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy. Zubizarreta PA; D'Antonio G; Raslawski E; Gallo G; Preciado MV; Casak SJ; Scopinaro M; Morales G; Sackmann-Muriel F Cancer; 2000 Aug; 89(3):690-5. PubMed ID: 10931470 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Chua DT; Nicholls JM; Sham JS; Au GK Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]